{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:58:11Z","timestamp":1756810691068},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The efficacy of pulmonary vein isolation (PVI) alone is not guaranteed for persistent atrial fibrillation (PeAF), and it is unclear which type of ablation approach should be applied in addition to PVI. This study aimed to compare outcomes and prognosis between empirical linear ablation and low-voltage area (LVA) ablation after PVI for PeAF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We enrolled 128 patients with PeAF who were assigned to the linear ablation group (n\u2009=\u200964) and the LVA ablation group (n\u2009=\u200964) using a propensity score-matched model. After PVI and cardioversion, the patients underwent either empirical linear ablation or LVA ablation during sinus rhythm. All patients in the linear ablation group underwent both roof line and mitral valve isthmus (MVI) ablations. An electrical-guided ablation targeting LVA (&lt;\u20090.5\u00a0mV) was performed in the LVA group. When there was no LVA in the LVA group, only PVI was applied. We compared the procedural outcomes and recurrence after ablation between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The baseline characteristics were well-balanced between the two groups. Fifty patients had LVA (22 and 28 patients in the linear and LVA groups). The roof and MVI lines were completed in 100% and 96.9% of the patients. During the mean follow-up of 279.5\u2009\u00b1\u2009161.3\u00a0days, the LVA group had significantly lower recurrence than the linear group (15 patients [23%] vs. 29 patients [45%], <jats:italic>p<\/jats:italic>\u2009=\u20090.014). Thirty-five patients were prescribed antiarrhythmic drugs during the follow-up period (linear group, n\u2009=\u200917; LVA group, n\u2009=\u200918); amiodarone and bepridil were administered to most of the patients (15 and 17 patients, respectively). The difference in the prognosis was relevant among the patients with LVA, while this trend was not observed in those without LVA. The LVA ablation group demonstrated significantly lower radiofrequency energy and shorter procedural time compared to the linear ablation group. The recurrence of atrial flutter was more likely to occur in the linear group than in the LVA group (14 [22%] vs. 6 [9.4%], <jats:italic>p<\/jats:italic>\u2009=\u20090.052).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The electrophysiological-guided LVA ablation is more effective than empirical linear ablation in PeAF patients with LVA. Unnecessary empirical linear ablation might have a risk of iatrogenic gap and atrial flutter recurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02460-9","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T09:02:52Z","timestamp":1642842172000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of the empirical linear ablation and low voltage area-guided ablation in addition to pulmonary vein isolation in patients with persistent atrial fibrillation: a propensity score-matched analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Noriyuki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiki","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Tatami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuya","family":"Inden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,22]]},"reference":[{"issue":"10","key":"2460_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM199809033391003","volume":"339","author":"M Ha\u00efssaguerre","year":"1998","unstructured":"Ha\u00efssaguerre M, Ja\u00efs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659\u201366.","journal-title":"N Engl J Med"},{"issue":"9","key":"2460_CR2","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1253\/circj.CJ-10-0693","volume":"74","author":"A Takahashi","year":"2010","unstructured":"Takahashi A. Catheter ablation is established as a treatment option for atrial fibrillation\u2014is catheter ablation established as a treatment option of atrial fibrillation? (Pro). Circ J. 2010;74(9):1972\u20137.","journal-title":"Circ J"},{"issue":"9","key":"2460_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1161\/01.CIR.0000157153.30978.67","volume":"111","author":"R Cappato","year":"2005","unstructured":"Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111(9):1100\u20135.","journal-title":"Circulation"},{"issue":"1","key":"2460_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijcard.2013.08.083","volume":"169","author":"SH Wu","year":"2013","unstructured":"Wu SH, Jiang WF, Gu J, Zhao L, Wang YL, Liu YG, et al. Benefits and risks of additional ablation of complex fractionated atrial electrograms for patients with atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2013;169(1):35\u201343.","journal-title":"Int J Cardiol"},{"issue":"2","key":"2460_CR5","doi-asserted-by":"publisher","first-page":"e004811","DOI":"10.1161\/JAHA.116.004811","volume":"6","author":"TH Kim","year":"2017","unstructured":"Kim TH, Uhm JS, Kim JY, Joung B, Lee MH, Pak HN. Does additional electrogram-guided ablation after linear ablation reduce recurrence after catheter ablation for longstanding persistent atrial fibrillation? A prospective randomized study. J Am Heart Assoc. 2017;6(2):e004811.","journal-title":"J Am Heart Assoc."},{"issue":"10","key":"2460_CR6","doi-asserted-by":"publisher","first-page":"e0164989","DOI":"10.1371\/journal.pone.0164989","volume":"11","author":"M Qin","year":"2016","unstructured":"Qin M, Liu X, Wu SH, Zhang XD. Atrial substrate modification in atrial fibrillation: targeting GP or CFAE? Evidence from meta-analysis of clinical trials. PLoS ONE. 2016;11(10):e0164989.","journal-title":"PLoS ONE"},{"issue":"12","key":"2460_CR7","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1540-8167.2011.02112.x","volume":"22","author":"S Matsuo","year":"2011","unstructured":"Matsuo S, Yamane T, Date T, Hioki M, Narui R, Ito K, et al. Completion of mitral isthmus ablation using a steerable sheath: prospective randomized comparison with a nonsteerable sheath. J Cardiovasc Electrophysiol. 2011;22(12):1331\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"48","key":"2460_CR8","doi-asserted-by":"publisher","first-page":"e13060","DOI":"10.1097\/MD.0000000000013060","volume":"97","author":"JH Lee","year":"2018","unstructured":"Lee JH, Nam GB, Go TH, Hwang J, Kim M, Hwang YM, et al. Alternative strategies to improve success rate of mitral isthmus block. Medicine. 2018;97(48):e13060.","journal-title":"Medicine."},{"issue":"19","key":"2460_CR9","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","volume":"372","author":"A Verma","year":"2015","unstructured":"Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812\u201322.","journal-title":"N Engl J Med"},{"issue":"23","key":"2460_CR10","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1093\/eurheartj\/ehl093","volume":"27","author":"S Willems","year":"2006","unstructured":"Willems S, Klemm H, Rostock T, Brandstrup B, Ventura R, Steven D, et al. Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison. Eur Heart J. 2006;27(23):2871\u20138.","journal-title":"Eur Heart J"},{"issue":"24","key":"2460_CR11","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.jacc.2015.09.088","volume":"66","author":"J Vogler","year":"2015","unstructured":"Vogler J, Willems S, Sultan A, Schreiber D, L\u00fcker J, Servatius H, et al. Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol. 2015;66(24):2743\u201352.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2460_CR12","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.cjca.2020.03.040","volume":"36","author":"PB Nery","year":"2020","unstructured":"Nery PB, Alqarawi W, Nair GM, Sadek MM, Redpath CJ, Golian M, et al. Catheter ablation of low-voltage areas for persistent atrial fibrillation: procedural outcomes using high-density voltage mapping. Can J Cardiol. 2020;36(12):1956\u201364.","journal-title":"Can J Cardiol"},{"issue":"4","key":"2460_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/joa3.12491","volume":"37","author":"A Nogami","year":"2021","unstructured":"Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, et al. JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. J Arrhythm. 2021;37(4):709\u2013870.","journal-title":"J Arrhythm"},{"issue":"10","key":"2460_CR14","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","volume":"14","author":"H Calkins","year":"2017","unstructured":"Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275\u2013444.","journal-title":"Heart Rhythm"},{"issue":"7","key":"2460_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jacep.2020.02.005","volume":"6","author":"S Yanagisawa","year":"2020","unstructured":"Yanagisawa S, Inden Y, Ohguchi S, Nagao T, Fujii A, Tomomatsu T, et al. Periprocedural management of cardiac tamponade during catheter ablation for AF under uninterrupted DOAC and warfarin. JACC Clin Electrophysiol. 2020;6(7):786\u201395.","journal-title":"JACC Clin Electrophysiol"},{"issue":"10","key":"2460_CR16","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.jacep.2017.08.016","volume":"3","author":"V Calzolari","year":"2017","unstructured":"Calzolari V, De Mattia L, Indiani S, Crosato M, Furlanetto A, Licciardello C, et al. In vitro validation of the lesion size index to predict lesion width and depth after irrigated radiofrequency ablation in a porcine model. JACC Clin Electrophysiol. 2017;3(10):1126\u201335.","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"2460_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/joa3.12537","volume":"37","author":"G Matsuura","year":"2021","unstructured":"Matsuura G, Kishihara J, Fukaya H, Oikawa J, Ishizue N, Saito D, et al. Optimized lesion size index (o-LSI): a novel predictor for sufficient ablation of pulmonary vein isolation. J Arrhythm. 2021;37(3):558\u201365.","journal-title":"J Arrhythm"},{"issue":"13","key":"2460_CR18","doi-asserted-by":"publisher","first-page":"e015927","DOI":"10.1161\/JAHA.120.015927","volume":"9","author":"M Masuda","year":"2020","unstructured":"Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, et al. Additional low-voltage-area ablation in patients with paroxysmal atrial fibrillation: results of the randomized controlled VOLCANO trial. J Am Heart Assoc. 2020;9(13):e015927.","journal-title":"J Am Heart Assoc."},{"issue":"11","key":"2460_CR19","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/europace\/eux310","volume":"20","author":"S Kircher","year":"2018","unstructured":"Kircher S, Arya A, Altmann D, Rolf S, Bollmann A, Sommer P, et al. Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study. Europace. 2018;20(11):1766\u201375.","journal-title":"Europace."},{"key":"2460_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10840-021-00943-x","volume":"63","author":"OM Aldaas","year":"2021","unstructured":"Aldaas OM, Lupercio F, Lin AY, Han FT, Hoffmayer KS, Raissi F, et al. Ablation of mitral annular flutter ablation utilizing a left atrial anterior line versus a lateral mitral isthmus line: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2021;63:87\u201395.","journal-title":"J Interv Card Electrophysiol."},{"issue":"3","key":"2460_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jacc.2016.10.065","volume":"69","author":"J Seitz","year":"2017","unstructured":"Seitz J, Bars C, Th\u00e9odore G, Beurtheret S, Lellouche N, Bremondy M, et al. AF ablation guided by spatiotemporal electrogram dispersion without pulmonary vein isolation: a wholly patient-tailored approach. J Am Coll Cardiol. 2017;69(3):303\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2460_CR22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jacc.2012.05.022","volume":"60","author":"SM Narayan","year":"2012","unstructured":"Narayan SM, Krummen DE, Shivkumar K, Clopton P, Rappel WJ, Miller JM. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial. J Am Coll Cardiol. 2012;60(7):628\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2460_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/jce.13437","volume":"29","author":"S Honarbakhsh","year":"2018","unstructured":"Honarbakhsh S, Hunter RJ, Dhillon G, Ullah W, Keating E, Providencia R, et al. Validation of a novel mapping system and utility for mapping complex atrial tachycardias. J Cardiovasc Electrophysiol. 2018;29(3):395\u2013403.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"2460_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jce.14278","volume":"31","author":"Y Takahashi","year":"2020","unstructured":"Takahashi Y, Akiyoshi K, Sekigawa M, Yagishita A, Yamamoto T, Maeda S, et al. Endocardial contact mapping of the left atrial appendage in persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2020;31(1):112\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"2460_CR25","doi-asserted-by":"publisher","first-page":"e003382","DOI":"10.1161\/CIRCEP.115.003382","volume":"9","author":"G Yang","year":"2016","unstructured":"Yang G, Yang B, Wei Y, Zhang F, Ju W, Chen H, et al. Catheter ablation of nonparoxysmal atrial fibrillation using electrophysiologically guided substrate modification during sinus rhythm after pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2016;9(2):e003382.","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"4","key":"2460_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/europace\/eut265","volume":"16","author":"T Yamaguchi","year":"2014","unstructured":"Yamaguchi T, Tsuchiya T, Nagamoto Y, Miyamoto K, Murotani K, Okishige K, et al. Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regards to substrates and pulmonary vein reconnections. Europace. 2014;16(4):511\u201320.","journal-title":"Europace"},{"issue":"2","key":"2460_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5105\/jse.29.133","volume":"29","author":"T Tsuchiya","year":"2009","unstructured":"Tsuchiya T. Substrate of atrial fibrillation is reated to results of atrial fibrillation ablation: a concept of no low voltage no LA body AF (in Japanese). Jpn J Electrocardiol. 2009;29(2):133\u201340.","journal-title":"Jpn J Electrocardiol"},{"issue":"11","key":"2460_CR28","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1540-8167.2005.50192.x","volume":"16","author":"G Fassini","year":"2005","unstructured":"Fassini G, Riva S, Chiodelli R, Trevisi N, Berti M, Carbucicchio C, et al. Left mitral isthmus ablation associated with PV Isolation: long-term results of a prospective randomized study. J Cardiovasc Electrophysiol. 2005;16(11):1150\u20136.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"suppl_1","key":"2460_CR29","first-page":"A16225-A","volume":"134","author":"T-H Kim","year":"2016","unstructured":"Kim T-H, Park J, Uhm J-S, Kim J-Y, Joung B, Lee M-H, et al. Abstract 16225: durability of left atrial linear ablation and clinical outcome after catheter ablation for persistent atrial fibrillation. Circulation. 2016;134(suppl_1):A16225-A.","journal-title":"Circulation."},{"issue":"3","key":"2460_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/jce.12576","volume":"26","author":"K Yoshitani","year":"2015","unstructured":"Yoshitani K, Miyamoto T, Sato Y, Takatsu Y. Another gate keeper to protect the mitral isthmus? Importance of the vein of Marshall. J Cardiovasc Electrophysiol. 2015;26(3):352\u20133.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"12","key":"2460_CR31","doi-asserted-by":"publisher","first-page":"e008884","DOI":"10.1161\/CIRCEP.120.008884","volume":"13","author":"T Nakashima","year":"2020","unstructured":"Nakashima T, Pambrun T, Vlachos K, Goujeau C, Andr\u00e9 C, Krisai P, et al. Impact of vein of marshall ethanol infusion on mitral isthmus block: efficacy and durability. Circ Arrhythm Electrophysiol. 2020;13(12):e008884.","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"18","key":"2460_CR32","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.jacc.2014.01.032","volume":"63","author":"JL B\u00e1ez-Escudero","year":"2014","unstructured":"B\u00e1ez-Escudero JL, Keida T, Dave AS, Okishige K, Valderr\u00e1bano M. Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation. J Am Coll Cardiol. 2014;63(18):1892\u2013901.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2460_CR33","doi-asserted-by":"publisher","first-page":"e010001","DOI":"10.1161\/CIRCEP.121.010001","volume":"14","author":"T Kamakura","year":"2021","unstructured":"Kamakura T, Derval N, Duchateau J, Denis A, Nakashima T, Takagi T, et al. Vein of marshall ethanol infusion: feasibility, pitfalls, and complications in over 700 patients. Circ Arrhythm Electrophysiol. 2021;14(8):e010001.","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"6","key":"2460_CR34","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1161\/CIRCEP.111.964817","volume":"4","author":"N Sawhney","year":"2011","unstructured":"Sawhney N, Anand K, Robertson CE, Wurdeman T, Anousheh R, Feld GK. Recovery of mitral isthmus conduction leads to the development of macro-reentrant tachycardia after left atrial linear ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4(6):832\u20137.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"2460_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1540-8167.2006.00516.x","volume":"17","author":"S Kamanu","year":"2006","unstructured":"Kamanu S, Tan AY, Peter CT, Hwang C, Chen PS. Vein of Marshall activity during sustained atrial fibrillation. J Cardiovasc Electrophysiol. 2006;17(8):839\u201346.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8","key":"2460_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1540-8167.2007.00848.x","volume":"18","author":"LW Lo","year":"2007","unstructured":"Lo LW, Tai CT, Lin YJ, Chang SL, Wongcharoen W, Hsieh MH, et al. Mechanisms of recurrent atrial fibrillation: comparisons between segmental ostial versus circumferential pulmonary vein isolation. J Cardiovasc Electrophysiol. 2007;18(8):803\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"2460_CR37","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/jce.15002","volume":"32","author":"T Takamiya","year":"2021","unstructured":"Takamiya T, Nitta J, Inaba O, Sato A, Inamura Y, Murata K, et al. Impact of diagnosis-to-ablation time on non-pulmonary vein triggers and ablation outcomes in persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2021;32(5):1251\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"2","key":"2460_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/jce.14830","volume":"32","author":"S Tohoku","year":"2021","unstructured":"Tohoku S, Fukunaga M, Nagashima M, Korai K, Hirokami J, Yamamoto K, et al. Clinical impact of eliminating nonpulmonary vein triggers of atrial fibrillation and nonpulmonary vein premature atrial contractions at initial ablation for persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2021;32(2):224\u201334.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"2460_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jjcc.2018.04.012","volume":"72","author":"H Mori","year":"2018","unstructured":"Mori H, Kato R, Ikeda Y, Goto K, Tanaka S, Asano S, et al. The influence of the electrodes spacing of a mapping catheter on the atrial voltage substrate map. J Cardiol. 2018;72(5):434\u201342.","journal-title":"J Cardiol"},{"issue":"4","key":"2460_CR40","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1536\/ihj.21-067","volume":"62","author":"S Huang","year":"2021","unstructured":"Huang S, Zhao T, Liu C, Qin A, Dong S, Yuan B, et al. Portable device improves the detection of atrial fibrillation after ablation. Int Heart J. 2021;62(4):786\u201391.","journal-title":"Int Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02460-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T09:05:01Z","timestamp":1642842301000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02460-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2460"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02460-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,22]]},"assertion":[{"value":"22 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of Toyota Kosei Hospital. The study was performed in compliance with the principles of the Declaration of Helsinki. Informed consent was obtained from all patients prior to the procedure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Yanagisawa is affiliated with a department sponsored by Medtronic Japan. Other authors have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}